← All stocks

BIODESIX INC

BDSX Net buying
CIK 0001439725 #3725 in the set updated 17 Sep 2026
Bought (12 mo)
$4.23M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$118.39K
$0.00 on a plan · $2.29K straight out of an exercise
Sold at will
$116.10K
15 of 20 sales
Net
+$4.11M
+$4.11M against sales at will

By person

12 insiders · 29 transactions
1.8×

Scott Hutton holds only 1.8 times base salary in stock. $1.19M of shares against $643.40K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott Hutton last reported holding, valued at $24.47, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SCHULER JACK W
10% owner
$4.23M (9)
+$4.23M
555,810
$13.60M
Hutton Scott
President & CEO
$64.27K (4)
−$64.27K
48,767
$1.19M
Cowie Robin Harper
CFO, Sec'y & Treasurer
$19.13K (4)
−$19.13K
16,231
$397.11K
O'Kane Kieran
Chief Commercial Officer
$15.34K (4)
−$15.34K
9,819
$240.23K
Pestano Gary Anthony
Chief Development Officer
$15.15K (4)
−$15.15K
10,359
$253.44K
Vazquez Chris
Chief Accounting Officer
$4.49K (4)
−$4.49K
1,586
$38.80K
Kennedy Lawrence T. Jr
Director
10,411,024
$254.72M
+1.0%
Strobeck Matthew
Director
2,606,879
$63.78M
+1.6%
PATIENCE JOHN
Director
2,178,681
$53.30M
+7.4%
Watts Charles M
Director
421,705
$10.32M
+12.4%
MASSARANY HANY
Director
363,499
$8.89M
+15.5%
Franchi Jean M.
Director
108,140
$2.65M
+32.2%

No percentages here. This company's share count has moved by a factor of 18.4 over the window, from 7,955,685 to 146,633,352 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Cowie Robin Harper
10 Nov 2025
CFO, Sec'y & Treasurer
Sold after exercise
50
$7.62
$381.00
Hutton Scott
10 Nov 2025
President & CEO
Sold after exercise
189
$7.62
$1.44K
O'Kane Kieran
10 Nov 2025
Chief Commercial Officer
Sold after exercise
25
$7.62
$190.50
Pestano Gary Anthony
10 Nov 2025
Chief Development Officer
Sold after exercise
23
$7.62
$175.26
Vazquez Chris
10 Nov 2025
Chief Accounting Officer
Sold after exercise
13
$7.62
$99.06

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,019
History held since 3 Nov 2020